$65,469,511
ABBOTT: TO CONDUCT CLINICAL TRAINING AND VALIDATION STUDIES TO SUPPORT A FUTURE FDA MARKETING APPLICATION WITH AN EXPANDED INDICATION FOR USE OF THE ABBOTT TBI TEST ? TO AID IN THE DIAGNOSIS OF TRAUMATIC BRAIN INJURY IN ADULTS AND PEDIATRIC PATIENTS.
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Abbott conducts clinical training and validation studies for an expanded FDA indication of its traumatic brain injury diagnostic test in adults and pediatric patients.
Improved TBI diagnostics accelerate clinical decision-making and reduce misdiagnosis in emergency and pediatric settings, supporting public health preparedness infrastructure.
This obligation on the 2022 Abbott contract signals continued investment in domestic diagnostic-device validation, supporting Abbott's manufacturing and clinical supply chain.
Strengthening U.S. diagnostic capabilities in TBI reduces reliance on foreign diagnostic platforms and reinforces American biotech leadership in point-of-care testing.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-04. Cost: $0.003046.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75A50122C00046_7505_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.